Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer

Background The prognosis of patients with non-small cell lung cancer (NSCLC) is important, as patients with resectable disease and poor prognostic variables might benefit from neoadjuvant therapy. The goal of this study is to evaluate SUVmax, SUVmax ratio, CT volume (CTvol), metabolic tumour volume...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European radiology 2015-11, Vol.25 (11), p.3361-3367
Hauptverfasser:	Domachevsky, L., Groshar, D., Galili, R., Saute, M., Bernstine, H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Chest Cone-Beam Computed Tomography Diagnostic Radiology Female Fluorodeoxyglucose F18 Humans Imaging Internal Medicine Interventional Radiology Lung cancer Lung Neoplasms - diagnostic imaging Lung Neoplasms - mortality Lung Neoplasms - pathology Lymphatic Metastasis - pathology Male Medicine Medicine & Public Health Multimodal Imaging Neoadjuvant Therapy Neoplasm Staging Neuroradiology Positron-Emission Tomography Prognosis Proportional Hazards Models Radiology Radiopharmaceuticals Retrospective Studies Tomography, X-Ray Computed Tumor Burden Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!